Abcuro is developing therapies for autoimmune diseases and certain cancers by targeting specific immune cells.
Market
Healthcare
Location
Newton,
Massachusetts,
USA
Coinvestors
NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax, Mass General Brigham Ventures, New Leaf Ventures, abrdn, BlackRock, Eurofarma Ventures, Soleus Capital